The company will shell out $2.2 billion over allegations of marketing misconduct for Risperdal, Invega and Natrecor.
Quintiles buys a CRO; Forest and Almirall delay their COPD combo drug; and Paula Deen may pop up on the Food Network Sunday
Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results
Lance Armstrong's story is about more than cycling. PR and brand experts weighed in on how they would safeguard his cancer foundation's reputation.
Viagra and Cialis took top honors for most trusted pharmaceutical brands in a poll of physicians.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.